Release Date: 29/06/23 19:07 Summary: Estimated Distribution Announcement Price Sensitive: Yes Download Document 228.9KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%